Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Trogarzo IM (ibalizumab intramuscular) / Theratechnologies
NCT03913195: Study of the Safety of Trogarzo™ Administered as an Undiluted "IV Push" or an Intramuscular Injection	Completed	3	46	US	ibalizumab-uiyk, Trogarzo	TaiMed Biologics Inc., Westat	HIV-1-infection	10/22	10/22